| Should evaluation for minimal residual disease be routine in acute myeloid leukemia? | |
| | |
MedLine Citation:
|
PMID: 23380603 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
PURPOSE OF REVIEW: In patients with acute myeloid leukemia (AML), measuring response to treatment is essential to guide clinical decisions. Methods for detecting disease beyond the resolution limit of morphology (i.e., minimal residual disease, MRD) are now widely available. We here discuss their merits and the results of side-to-side comparisons. RECENT FINDINGS: The ever-increasing comprehension of the molecular genetics of AML has led to the identification of targets for molecular monitoring of MRD in the majority of AML cases. Likewise, virtually all cases express aberrant immunophenotypes suitable for MRD monitoring by flow cytometry, a progress bolstered by powerful new-generation instruments. The clinical significance of MRD monitoring by either approach has been corroborated by recent results. However, with few exceptions, most of the studies continue to rely on retrospectively determined cut-off levels and time points. Moreover, when applied in parallel, the two approaches have yielded contradictory results. SUMMARY: MRD monitoring can help predicting the risk of relapse better than morphology and also provide endpoints for clinical testing of experimental agents. MRD can be applied to guide therapy but one must carefully consider the characteristics of the methods used and the degree of expertise of the laboratory performing the test. |
| | |
Authors:
|
Elaine Coustan-Smith; Dario Campana |
Related Documents
:
|
21343823 - John hutchinson, 1811-1861: the first respiratory disease epidemiologist. 21122523 - Assessment of activity of crohn's disease by doppler sonography of superior mesenteric ... 8633583 - Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: compa... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Current opinion in hematology Volume: 20 ISSN: 1531-7048 ISO Abbreviation: Curr. Opin. Hematol. Publication Date: 2013 Mar |
Date Detail:
|
Created Date: 2013-02-05 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9430802 Medline TA: Curr Opin Hematol Country: United States |
Other Details:
|
Languages: eng Pagination: 86-92 Citation Subset: IM |
Affiliation:
|
Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The evolving molecular genetic landscape in acute myeloid leukaemia.
Next Document: Pupil centroid shift and cyclotorsion in bilateral wavefront-guided laser refractive surgery and the...